SEOUL-- The head of Celltrion Inc., a South Korean bio-pharmaceutical firm, became the country's 10th richest stock holder as of end-July, data showed Sunday, becoming the second self-made figure to be included in the top 10 bracket.
According to data compiled by Chaebul.com, Seo Jung-jin, the company's president, held shares worth 2.4 trillion won (US$2.13 billion) as of Friday, after Celltrion Healthcare Co. went public on the country's secondary KOSDAQ market.
While Seo does not directly hold shares in Celltrion Inc., he still holds a 36.2 percent stake in Celltrion Healthcare, along with a 93.9 percent stake in Celltrion Holdings Co.
Celltrion and Celltrion Healthcare stand as the No. 1 and No. 2 players in terms of market cap on the tech-heavy KOSDAQ, respectively. Celltrion Healthcare was listed on the market for the first time Friday.
Seo is the second self-made figure to be included on the list, along with Bang Joon-hyuk, the head of Netmarble Games, who is ranked in sixth place with shares worth 3.2 trillion won.
Others on the list were from owner families of South Korean conglomerates.
Lee Kun-hee, the head of Samsung Electronics Co., stood in the top spot with shares worth 17.9 trillion won, followed by his heir apparent and only son Lee Jae-yong with 7.8 trillion won.
Suh Kyung-bae, chief of South Korea's top cosmetics maker AmorePacific Co., followed with 7.4 trillion won, trailed by Chung Mong-koo, chairman of Hyundai Motor Group, with 4.8 trillion won.
Chey Tae-won, the head of No. 3 conglomerate SK Group, held shares worth 4.3 trillion won, the data also showed.
Source: Yonhap News Agency